全文获取类型
收费全文 | 7610篇 |
免费 | 487篇 |
国内免费 | 76篇 |
专业分类
耳鼻咽喉 | 65篇 |
儿科学 | 165篇 |
妇产科学 | 349篇 |
基础医学 | 890篇 |
口腔科学 | 112篇 |
临床医学 | 853篇 |
内科学 | 1780篇 |
皮肤病学 | 91篇 |
神经病学 | 554篇 |
特种医学 | 411篇 |
外科学 | 984篇 |
综合类 | 126篇 |
一般理论 | 3篇 |
预防医学 | 379篇 |
眼科学 | 168篇 |
药学 | 565篇 |
中国医学 | 43篇 |
肿瘤学 | 635篇 |
出版年
2023年 | 45篇 |
2022年 | 81篇 |
2021年 | 191篇 |
2020年 | 91篇 |
2019年 | 156篇 |
2018年 | 206篇 |
2017年 | 146篇 |
2016年 | 119篇 |
2015年 | 228篇 |
2014年 | 287篇 |
2013年 | 375篇 |
2012年 | 587篇 |
2011年 | 540篇 |
2010年 | 306篇 |
2009年 | 328篇 |
2008年 | 485篇 |
2007年 | 407篇 |
2006年 | 408篇 |
2005年 | 418篇 |
2004年 | 378篇 |
2003年 | 312篇 |
2002年 | 260篇 |
2001年 | 215篇 |
2000年 | 183篇 |
1999年 | 188篇 |
1998年 | 57篇 |
1997年 | 38篇 |
1996年 | 40篇 |
1995年 | 47篇 |
1994年 | 32篇 |
1993年 | 20篇 |
1992年 | 107篇 |
1991年 | 76篇 |
1990年 | 79篇 |
1989年 | 59篇 |
1988年 | 70篇 |
1987年 | 72篇 |
1986年 | 62篇 |
1985年 | 64篇 |
1984年 | 65篇 |
1983年 | 31篇 |
1982年 | 23篇 |
1979年 | 37篇 |
1978年 | 26篇 |
1977年 | 23篇 |
1976年 | 17篇 |
1975年 | 33篇 |
1974年 | 23篇 |
1973年 | 19篇 |
1971年 | 17篇 |
排序方式: 共有8173条查询结果,搜索用时 15 毫秒
101.
102.
Hao-Hueng Chang Chun-Liang Yeh Yin-Lin Wang Yi-Chao Huang Shang-Jye Tsai Yu-Ting Li Ju-Hsuan Yang Chun-Pin Lin 《Dental materials》2021,37(4):682-689
ObjectiveThe lack of a PDL, which acts as an energy absorber, is a contributor to implants’ early failure; however, these discrepancies are not well understood because of limited in vivo research. This study investigated the discrepancy in biomechanical behaviors between natural teeth and dental implants by detecting micro-movements in vivo.MethodsWe designed a device that could measure precisely mechanical behaviors such as creep, stress relaxation, and hysteresis by using load–control displacement on teeth and implants. We also compared energy dissipation between natural teeth and dental implants by subtracting the area of the hysteresis loop of natural teeth from that of dental implants.ResultsBiphasic curves with an initial phase of rapid response and a subsequent phase of slow response were confirmed in creep and stress relaxation curves for the load–time relationship in natural teeth. By contrast, the behavior of creep or stress relaxation was less prominent when the dental implants were tested. We observed that the periodontal ligament under an axial intrusive load of 300 g in a loading rate 3 g/s could dissipate the energy of 7.35 ± 1.18 × 10?2 mJ, approximately 50 times that of the dental implants (1.47 ± 1.22 × 10?3) with statistically significant (p < 0.05).SignificanceWe confirmed natural teeth could achieve greater energy dissipation compared to dental implants, which owe to that natural teeth exhibited fluid and viscoelastic properties. 相似文献
103.
104.
105.
106.
107.
Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model 总被引:28,自引:0,他引:28 下载免费PDF全文
Griscelli F Li H Cheong C Opolon P Bennaceur-Griscelli A Vassal G Soria J Soria C Lu H Perricaudet M Yeh P 《Proceedings of the National Academy of Sciences of the United States of America》2000,97(12):6698-6703
The objective of the present study was to evaluate the antitumor effect of a defective adenovirus expressing a secretable angiostatin-like molecule (AdK3) in combination with radiotherapy in rat C6 gliomas s.c. preestablished into athymic mice. In vitro, the combination regimen was significantly (P < 0.001) more cytotoxic for human microcapillary endothelial cells than either treatment alone, whereas survival of C6 glioma cells was not affected in the conditions used. Radiotherapy and AdK3 gene delivery was then studied on well established C6 xenografts (165 +/- 70 mm(3)). In these tumors, AdK3 intratumoral injections had only a marginal effect. Interestingly, when experimental radiotherapy was added, significantly higher (P < 0.005), and possibly synergistic, antitumoral effects were observed that tightly correlated a marked decrease of intratumoral vascularization. The combination of radiotherapy and AdK3 intratumoral injections also revealed a significant (P < 0.05) inhibition of tumor growth as compared with either treatment alone for larger tumors (467 +/- 120 mm(3)). Altogether, these data emphasize the potential of combining a destructive strategy directed against the tumor cells with an anti-angiogenic approach to fight cancer. 相似文献
108.
Interaction between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding 总被引:9,自引:0,他引:9
BACKGROUND: Helicobacter pylori and non-steroidal anti-inflammatory drugs (NSAIDs) are the two primary causes of peptic ulcer disease. How H. pylori and NSAIDs interact and influence the development of ulcer bleeding is still not clear. METHODS: A hospital-based, age- and sex-matched case-control study was conducted. Multivariate and stratified analyses were performed for further evaluation of the interaction between H. pylori and NSAIDs. RESULTS: Ninety-seven patients (52 gastric ulcers, 45 duodenal ulcers) and 97 non-ulcer controls were enrolled in the study. H. pylori and NSAIDs were both found to be independent risk factors for ulcer bleeding (H. pylori odds ratio, 2.22; 95% confidence interval (CI), 1.23-4.01; NSAIDs odds ratio, 4.57; 95% CI, 2.50-8.35). There was no synergistic effect. In contrast, a negative interaction was observed in the logistic regression and stratified analysis, although the difference was not significant (H. pylori adjusted odds ratio, 3.47; 95% CI, 1.73-6.95; NSAID adjusted odds ratio, 6.16; 95% CI, 3.14-12.09). CONCLUSION: H. pylori increases the risk of peptic ulcer bleeding but may play a protective role in NSAID users. 相似文献
109.
Shih-Chi Yeh Pao-Yuan Wang Yi-Wei Lou Kay-Hooi Khoo Michael Hsiao Tsui-Ling Hsu Chi-Huey Wong 《Proceedings of the National Academy of Sciences of the United States of America》2016,113(20):5592-5597
The cancer stem cells (CSCs) of glioblastoma multiforme (GBM), a grade IV astrocytoma, have been enriched by the expressed marker CD133. However, recent studies have shown that CD133− cells also possess tumor-initiating potential. By analysis of gangliosides on various cells, we show that ganglioside D3 (GD3) is overexpressed on eight neurospheres and tumor cells; in combination with CD133, the sorted cells exhibit a higher expression of stemness genes and self-renewal potential; and as few as six cells will form neurospheres and 20–30 cells will grow tumor in mice. Furthermore, GD3 synthase (GD3S) is increased in neurospheres and human GBM tissues, but not in normal brain tissues, and suppression of GD3S results in decreased GBM stem cell (GSC)-associated properties. In addition, a GD3 antibody is shown to induce complement-dependent cytotoxicity against cells expressing GD3 and inhibition of GBM tumor growth in vivo. Our results demonstrate that GD3 and GD3S are highly expressed in GSCs, play a key role in glioblastoma tumorigenicity, and are potential therapeutic targets against GBM.Glioblastoma multiforme (GBM) is extremely infiltrative and difficult to treat, and most patients develop recurrence after therapy. Over the past decade, many studies have suggested that bulk GBM tumors harbor cancer stem cells (CSCs) (1, 2), a distinct subpopulation of cancer cells that are able to initiate new tumors efficiently, have long-term self-renewal capacity, and survive better against chemo- or radiotherapy (2–4). CD133 has become a widely used marker for the enrichment of GBM CSCs (GSCs) and other tumor types (5–10). However, recent studies have shown that CD133 is not specific for GSCs because CD133− cells also possess tumor-initiating potential (11–13), indicating the need to identify more specific and exclusive markers for GSCs to facilitate our understanding of GSCs and therapeutic development against GBM. Several reports have proposed L1CAM, A2B5, integrin α6, MET, and CD15 as markers for GSCs (14–18). However, none of these protein markers could be used specifically to identify GSCs, and no study was reported with respect to glycans as potential markers, although glycan biosynthesis involves multiple genes and it is possible to create different structures in cancer progression. It is noted that ganglioside D2 (GD2) and ganglioside D3 (GD3) were found on the surface of neural stem cells (NSCs) and that stage-specific embryonic antigen 3 (SSEA3) and SSEA4 were found on embryonic stem cells and cancer cells (19–21), but there is no glycan marker found on the surface of GSCs.Gangliosides are sialic acid-containing glycosphingolipids (GSLs) that are most abundant in the nervous system (22). The expression levels and patterns of gangliosides during brain development shift from simple gangliosides, such as GM3 and GD3, to complex gangliosides, such as GM1, GD1a, GD1b, and GT1b (23, 24). Moreover, several unique ganglioside markers, including SSEA3, SSEA4, GD2, and GD3, have been identified in stem cells (19). GD3, a b-series ganglioside containing two sialic acids, is highly expressed in mouse and human embryonic NSCs (20, 25). In cancers, GD3 is highly accumulated in human primary melanoma tissues as well as in established melanoma cell lines (26), whereas human normal melanocytes express no or minimal levels of GD3 (27). Moreover, malignant gliomas contain higher levels of GD3, and its expression correlates with the degree of malignancy (28). GD3 is produced from the precursor GM3 by the activity of GD3 synthase (GD3S), which mediates the properties of CSCs through the c-MET signaling pathway and correlates with poor prognosis in triple-negative human breast tumors (29). These findings suggest that GD3 may play an important role in the transformation of normal cells into tumors, and imply that GD3 could be a cell surface marker for GSCs.This study was designed to identify glycan markers for the enrichment of GBM stem cells and then uses these enriched GBM stem cells to characterize tumorigenicity, their association with clinical GBM specimens, and their regulation in tumor progression. The results showed that GD2 and GD3 were positively stained on GBM neurospheres. We found that cells with high GD3 expression display functional characteristics of GSCs. Suppression of GD3S, a critical enzyme for GD3 synthesis, impeded neurosphere formation and tumor initiation. The expression of GD3S correlated with the grades of astrocytomas and mediated self-renewal through c-Met activation. Furthermore, a GD3 antibody was found to eliminate the GD3+ cells through complement-dependent cytotoxicity (CDC) in vitro and to suppress tumor growth in mice. These results suggest that GD3 could be a significant biomarker for GSCs, that CD3 could be combined with CD133 for the enrichment of GSCs, and that both GD3 and GD3S could be targets for the development of new therapies against GBM. 相似文献
110.
Jhen-Hao Jhan Hsin-Chih Yeh Yu-Han Chang Shiao-Jin Guu Wen-Jeng Wu Yii-Her Chou Ching-Chia Li 《Journal of diabetes and its complications》2018,32(7):688-692